Protara Therapeutics, Inc. (TARA)
Largest Insider Buys in Sector
TARA Stock Price History Chart
TARA Stock Performance
About Protara Therapeutics, Inc.
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed …
Insider Activity of Protara Therapeutics, Inc.
Over the last 12 months, insiders at Protara Therapeutics, Inc. have bought $0 and sold $1.75M worth of Protara Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Protara Therapeutics, Inc. have bought $2.31M and sold $1.19M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 9,065 shares for transaction amount of $34,810 was made by Shefferman Jesse (CEO and President) on 2022‑08‑11.
List of Insider Buy and Sell Transactions, Protara Therapeutics, Inc.
| 2024-09-12 | Sale | 10 percent owner | 126,301 0.6048% | $1.71 | $215,836 | +36.71% | ||
| 2024-09-11 | Sale | 10 percent owner | 32,600 0.1566% | $1.71 | $55,880 | +0.93% | ||
| 2024-09-10 | Sale | 10 percent owner | 25,500 0.1264% | $1.77 | $45,110 | +35.26% | ||
| 2024-09-09 | Sale | 10 percent owner | 36,492 0.1821% | $1.89 | $69,141 | +27.17% | ||
| 2024-07-16 | Sale | 10 percent owner | 11,396 0.0691% | $2.44 | $27,828 | -11.67% | ||
| 2024-07-11 | Sale | 10 percent owner | 47,993 0.2866% | $2.40 | $115,346 | 0.00% | ||
| 2024-07-10 | Sale | 10 percent owner | 18,061 0.1036% | $2.31 | $41,685 | 0.00% | ||
| 2024-07-09 | Sale | 10 percent owner | 8,497 0.0467% | $2.21 | $18,811 | 0.00% | ||
| 2024-07-01 | Sale | 10 percent owner | 8,288 0.0437% | $2.12 | $17,598 | 0.00% | ||
| 2024-06-28 | Sale | 10 percent owner | 17,994 0.0927% | $2.07 | $37,334 | 0.00% | ||
| 2024-06-27 | Sale | 10 percent owner | 46,574 0.2613% | $2.26 | $105,169 | 0.00% | ||
| 2024-06-25 | Sale | 10 percent owner | 12,725 0.0665% | $2.26 | $28,734 | +0.95% | ||
| 2024-05-31 | Sale | 10 percent owner | 5,824 0.0292% | $2.90 | $16,895 | -19.53% | ||
| 2024-05-30 | Sale | 10 percent owner | 9,230 0.0454% | $2.94 | $27,113 | -22.07% | ||
| 2024-05-22 | Sale | 10 percent owner | 9,800 0.0481% | $3.02 | $29,596 | -23.67% | ||
| 2024-05-21 | Sale | 10 percent owner | 33,000 0.1671% | $3.06 | $100,838 | -21.84% | ||
| 2024-05-17 | Sale | 10 percent owner | 70,885 0.3032% | $3.25 | $230,326 | -25.57% | ||
| 2024-05-10 | Sale | 10 percent owner | 151,700 0.7648% | $3.11 | $472,424 | -22.32% | ||
| 2024-05-09 | Sale | 10 percent owner | 30,600 0.1541% | $3.09 | $94,526 | -21.09% | ||
| 2022-12-30 | Sale | director | 15,473 0.1389% | $2.71 | $41,949 | -0.75% |
Insider Historical Profitability
| Opaleye Management Inc. | 10 percent owner | 45000 0.1311% | $5.39 | 15 | 20 | <0.0001% |
| O'Leary Brendan | director | 1387198 4.042% | $5.39 | 1 | 0 | |
| Abingworth LLP | 10 percent owner | 950000 2.7681% | $5.39 | 1 | 0 | |
| Haines Timothy | 950000 2.7681% | $5.39 | 1 | 0 | ||
| Shefferman Jesse | CEO and President | 879441 2.5625% | $5.39 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Opaleye Management Inc | $10.8M | 13.08 | 2.69M | 0% | +$0 | 2.38 | |
| The Vanguard Group | $1.71M | 2.08 | 427,612 | 0% | +$0 | <0.0001 | |
| Boxer Capital, LLC | $839,000.00 | 1.02 | 209,227 | 0% | +$0 | 0.02 | |
| Ikarian Capital LLC | $812,830.00 | 0.98 | 202,701 | +7.44% | +$56,288.30 | 0.11 | |
| Baker Bros Advisors LP | $800,681.00 | 0.97 | 199,671 | 0% | +$0 | 0.01 |